文献速递临床微生物分子诊断

评估MicroScan黏菌素孔与梯度扩散条对肠杆菌科黏菌素药敏检测

Evaluation of the MicroScan Colistin Well and Gradient Diffusion Strips for Colistin Susceptibility Testing in Enterobacteriaceae.
PubMed 文献 · J Clin Microbiol · 2019-04-26

该研究采用多步骤分层方法评估MicroScan黏菌素孔(4 μg/ml)与梯度扩散条检测肠杆菌科黏菌素耐药性的能力。MicroScan黏菌素孔与肉汤微量稀释法(BMD)的分类一致性为92.7%,极重大错误率10.7%;梯度扩散条分类一致性86.4%,极重大错误率53.6%。MicroScan黏菌素孔可检出所有携带mcr-1或mcr-2基因的分离株(n=16),而梯度扩散条仅对62.5%的这些分离株测得黏菌素MIC≥4。

要点

  • MicroScan黏菌素孔与BMD分类一致性92.7%,极重大错误率10.7%。
  • 梯度扩散条分类一致性86.4%,极重大错误率53.6%,不推荐用于黏菌素药敏。
  • MicroScan黏菌素孔可检出所有mcr-1/mcr-2阳性分离株(n=16),可作初筛。

核心结论

  • MicroScan黏菌素孔可作为初筛方法检测黏菌素MIC升高的肠杆菌科分离株,后续可进一步表征。

研究设计与样本

  • 采用多步骤分层方法评估MicroScan黏菌素孔(4 μg/ml)与梯度扩散条,以BMD为参考方法。
  • 在单一临床微生物实验室进行为期6个月的前瞻性表型和基因型研究,评估MicroScan黏菌素孔中生长分离株的一致性。
  • 回顾性分析该实验室2016年用MicroScan测试的所有大肠埃希菌、克雷伯菌属和肠杆菌属分离株。

主要发现

  • MicroScan黏菌素孔与BMD分类一致性为92.7%,极重大错误率为10.7%。
  • 梯度扩散条与BMD分类一致性为86.4%,极重大错误率为53.6%。
  • MicroScan黏菌素孔检出所有携带mcr-1或mcr-2基因的分离株(n=16),梯度扩散条仅对62.5%的这些分离株测得MIC≥4。
  • 前瞻性研究中,39株在MicroScan黏菌素孔中生长的分离株有37株经BMD确认黏菌素MIC≥4,但所有菌株PCR检测mcr-1和mcr-2均为阴性。
  • 2016年回顾性分析中,7,894株中有260株(3.3%)在MicroScan黏菌素孔中生长。

关键数值与推荐

  • MicroScan黏菌素孔浓度:4 μg/ml。
  • MicroScan黏菌素孔与BMD分类一致性:92.7%;极重大错误率:10.7%。
  • 梯度扩散条与BMD分类一致性:86.4%;极重大错误率:53.6%。

临床怎么用

  • 临床和公共卫生实验室可使用MicroScan黏菌素孔作为初筛,检测黏菌素MIC升高的分离株。
  • 初筛阳性分离株可进一步进行分子表征(如mcr基因检测)。

局限性

  • 前瞻性研究仅在单一临床微生物实验室进行,为期6个月。
  • 前瞻性研究中所有在MicroScan黏菌素孔生长的分离株mcr-1/mcr-2 PCR均为阴性,提示存在其他耐药机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Many laboratories are unable to perform colistin susceptibility testing. Diffusion-based antimicrobial susceptibility testing methods are not recommended, and not all laboratories have the capacity to perform broth microdilution (BMD). Using a multistep tiered approach, we investigated whether the adapted use of the MicroScan colistin well (4 μg/ml) could enhance laboratory capacity for the detection and subsequent molecular characterization of colistin-resistant Enterobacteriaceae For the MicroScan colistin well, categorical agreement with BMD was 92.7%, and the very major error rate was 10.7%. For gradient diffusion strips, the categorical agreement was 86.4%, and the very major error rate was 53.6%. The MicroScan colistin well detected all isolates carrying mcr-1 or mcr-2 genes (n = 16), but gradient diffusion strips identified an MIC of ≥4 for colistin for only 62.5% of these isolates. A 6-month prospective phenotypic and genotypic study performed at a single clinical microbiology laboratory assessed isolates growing in the MicroScan colistin well for concordance. While 37 of 39 isolates growing in the MicroScan colistin well displayed a colistin MIC of ≥4 by BMD, all were determined to be negative for the mcr-1 and mcr-2 genes by PCR. A retrospective review of all Escherichia coli, Klebsiella spp., and Enterobacter spp. tested by MicroScan at this laboratory in 2016 identified 260 of 7,894 (3.3%) isolates that grew in the MicroScan colistin well. Based on the data presented, clinical and public health laboratories could use the MicroScan colistin well as a first screen for the detection of isolates displaying elevated colistin MICs, which could then undergo further characterization.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Lutgring JD, Kim A, Campbell D, et al. Evaluation of the MicroScan Colistin Well and Gradient Diffusion Strips for Colistin Susceptibility Testing in Enterobacteriaceae. J Clin Microbiol. 2019. PMID: 30814260. doi:10.1128/JCM.01866-18

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。